Ian T. Bothwell - 05 May 2021 Form 4 Insider Report for Organicell Regenerative Medicine, Inc. (ZEOX)

Role
Chief Financial Officer, Director, 10%+ Owner
Signature
/s/ Ian Bothwell
Issuer symbol
ZEOX
Transactions as of
05 May 2021
Net transactions value
-$55,725
Form type
4
Filing time
07 May 2021, 21:45:14 UTC
Next filing
12 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCEL Common Stock Sale $15,050 -50,000 -0.03% $0.3010 150,050,000 05 May 2021 Direct
transaction OCEL Common Stock Sale $7,125 -25,000 -0.02% $0.2850 150,025,000 05 May 2021 Direct
transaction OCEL Common Stock Sale $10,400 -40,000 -0.03% $0.2600 149,985,000 06 May 2021 Direct
transaction OCEL Common Stock Sale $10,400 -40,000 -0.03% $0.2600 149,945,000 07 May 2021 Direct
transaction OCEL Common Stock Sale $12,750 -50,000 -0.03% $0.2550 149,895,000 07 May 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.